India Preclinical Research Market Overview and Insights:
According to MarkNtel Advisors Report, the India Preclinical Research Market size was valued at around USD 175 million in 2024 and is projected to reach USD 300 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.5% during the forecast period (2025-30).
India Preclinical Research Market research is an ongoing process. Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.
Boost strategic growth with in-depth market analysis - Get a free sample preview today!- https://www.marknteladvisors.com/query/request-sample/india-pre-clinical-research-market.html
Key Takeaways: Beneficial for Stakeholders and Clients:
- Historical Data: 2020-23
- Base Year: 2024
- Forecast Period: 2025-2030
What are the major challenges facing the India Preclinical Research Market?
Emergence of Targeted Therapies & Personalized Medicine – The emerging field of precision medicine and targeted therapies holds vast opportunities in the preclinical research market of India. Rapid growth can be seen in precession medicine specifically in oncology and immunology. It focuses on customized treatment based on the patient’s profile requiring intense preclinical research. Several international pharmaceutical companies like; Pfizer, Boehringer Ingelheim, AstraZeneca, and others are increasingly collaborating with Indian CROs for the preclinical stages, with a focus on target therapies, especially in oncology providing numerous opportunities for market growth.
In addition, the growing expertise of India in areas of molecular biology and genetic research can place India at the pinnacle of validation of biomarkers and identification of genetic targets that are crucial for precision medicine ultimately bringing more investments in the market.
Who are the Key Players Operating in the India Preclinical Research Industry?
The top companies of the India Preclinical Research market ruling the industry are:
- Syngene International Limited
- Dabur Research
- JSS Medical Research
- Jubilant Biosys Ltd.
- Sugen Life Sciences
- Eurofins Advinus
- GVRP
- Veeda Clinical Research Limited
- Axis Clinicals
- Syneos Health
- Ethicare-cro
- Liveon Biolabs Pvt. Ltd.
- IQVIA Inc.
- Bioneeds
- TheraIndx Lifesciences Pvt. Ltd.
- Abiogenesis Clinpharm
- Accutest Global
- Asiatic Clinical Research
- Bio Reliance Corporation
- Cliniminds
- Hi Tech Bio Laboratories
- GVK Biosciences
("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")
Buy specific sections of the report directly from the Table of Contents - https://www.marknteladvisors.com/research-library/india-pre-clinical-research-market.html
What is Included in India Preclinical Research Market Segmentation?
The report has segmented the market into the following categories:
By Model Type
- Patient-Derived Organoid (PDO) model- Market Size & Forecast 2020-2030, USD Million
- Patient-Derived Xenograft (PDX) model- Market Size & Forecast 2020-2030, USD Million
Out of them, the Patient-Derived Organoid (PDO) Model leads the market with more than 50% of the market share. PDO models are becoming increasingly crucial in preclinical research as they provide a closer stimulation of human biology than animal models. This allows more accurate preclinical testing and helps in creating drugs for highly complex diseases like cancer. In India, they find their major application in personalized medicine as they work on patient-specific tissues for testing drug efficacy, ultimately helping in tailored healthcare. With multiple investments and the provision of resources in the Indian market by pharmaceutical and biotechnology companies in advanced preclinical models like PDOs, there is a high improvement in the predictability of drug outcomes and streamlined clinical trial processes.
By Service
- Bioanalysis and DMPK studies- Market Size & Forecast 2020-2030, USD Million
- In vitro ADME- Market Size & Forecast 2020-2030, USD Million
- In-vivo PK- Market Size & Forecast 2020-2030, USD Million
- Toxicology testing- Market Size & Forecast 2020-2030, USD Million
- GLP- Market Size & Forecast 2020-2030, USD Million
- Non-GLP- Market Size & Forecast 2020-2030, USD Million
- Compound management- Market Size & Forecast 2020-2030, USD Million
- Process R&D- Market Size & Forecast 2020-2030, USD Million
- Custom synthesis- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Chemistry- Market Size & Forecast 2020-2030, USD Million
- Medicinal chemistry- Market Size & Forecast 2020-2030, USD Million
- Computation chemistry- Market Size & Forecast 2020-2030, USD Million
- Safety Pharmacology-Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
By End User
- Biopharmaceutical Companies- Market Size & Forecast 2020-2030, USD Million
- Government and academic institutes- Market Size & Forecast 2020-2030, USD Million
- Medical device companies- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
By Region
- North
- East
- West
- South
Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/india-pre-clinical-research-market.html
Frequently Asked Questions (FAQs)-
- What are the industry's overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
- What are the trends influencing the current scenario of the market?
- How has the India Preclinical Research industry been evolving in terms of geography & adoption?
- Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Further Queries:
Contact Us
MarkNtel Advisors
Phone: +1 628 895 8081, +91 120 4278433
E-Mail - sales@marknteladvisors.com
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh - 201301, India
Comments
0 comment